BioStock: Evaxion partners with MSD for vaccine development

Last fall, Evaxion Biotech announced entering a collaboration with a leading pharma company for the development of a vaccine against a bacterial pathogen causing severe healthcare issues. Now, we know that the partner is MSD. According to Evaxion, the initial phases of the collaboration have been successful. BioStock reached out to Evaxion’s CEO, Christian Kanstrup, to learn more.

Read the interview with Christian Kanstrup at biostock.se:

Evaxion partners with MSD for vaccine development - BioStock

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/en/